APOTHEEK RYCKAERT-VERSCHOOTE
APOTHEEK RYCKAERT-VERSCHOOTE has been active since 1984 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €390k and a net result of €267k. Equity remains stable across the filed fiscal years (±1.2% per year). Its solvency ranks better than 69% of 480 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
| Equity | €390k |
| Net result | €267k |
| Staff (FTE) | 0.2 |
| Better than sector | 69% |
Exceptional profile, strong across almost every axis.
All 5 axes are computed from data Checked has read.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 37.5% | 21.2% | |
| Net result | €267k | €32k | |
| Equity | €390k | €163k | |
| Gross operating margin | €405k | €281k | |
| Staff costs | €11k | €211k |
Figures by fiscal year and ratios
| Fiscal year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Deposit | abbreviated schema | abbreviated schema | abbreviated schema |
| Revenue | - | - | - |
| EBITDA | €388k | €396k | €366k |
| Net profit | €267k | €273k | €251k |
| Cash flow | €290k | €293k | €272k |
| Staff costs | €11k | €11k | €11k |
| Income taxes | €91k | €94k | €87k |
| Dividends | €272k | €278k | €256k |
| Total assets | €1.04M | €1.06M | €1.07M |
| Equity | €390k | €394k | €399k |
| Debt | €625k | €640k | €641k |
| of which ≤ 1y | €529k | €510k | €480k |
| of which > 1y | €95k | €128k | €160k |
| Working capital | €142k | €176k | €196k |
| Employees (FTE) | 0.2 | 0.2 | 0.2 |
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Current ratio | 1.27 | 1.35 | 1.41 |
| Quick ratio | 0.97 | 1.05 | 1.11 |
| Working capital ratio | 13.6% | 16.6% | 18.4% |
| Solvency | 37.5% | 37.1% | 37.3% |
| Debt / equity | 1.60 | 1.62 | 1.61 |
| Long-term debt ratio | 0.24 | 0.33 | 0.40 |
| Interest coverage | 37.02 | 35.23 | 32.23 |
| Gross margin | - | - | - |
| Net margin | - | - | - |
| ROA | 25.7% | 25.7% | 23.5% |
| ROE | 68.6% | 69.2% | 63.0% |
| EBITDA margin | - | - | - |
| Days sales outstanding | - | - | - |
| Days payable outstanding | - | - | - |
| Inventory turnover | - | - | - |
| Days inventory (DSI) | - | - | - |
Full annual accounts (26 line items)
| Line item | Code | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Balance sheet, Assets | ||||
| TOTAL ASSETS | 20/58 | €1.04M | €1.06M | €1.07M |
| Fixed assets | 21/28 | €369k | €376k | €393k |
| Tangible fixed assets | 22/27 | €368k | €374k | €392k |
| Financial fixed assets | 28 | €2k | €2k | €2k |
| Current assets | 29/58 | €671k | €686k | €677k |
| Stocks & contracts in progress | 3 | €157k | €149k | €142k |
| Amounts receivable within one year | 40/41 | €45k | €46k | €58k |
| Cash & bank | 54/58 | €349k | €384k | €386k |
| Balance sheet, Equity & liabilities | ||||
| TOTAL EQUITY & LIABILITIES | 10/49 | €1.04M | €1.06M | €1.07M |
| Equity | 10/15 | €390k | €394k | €399k |
| Contributions / capital | 10/11 | €19k | €19k | €19k |
| Reserves | 13 | €366k | €370k | €375k |
| Accumulated profits (losses) | 14 | €5k | €5k | €5k |
| Provisions & deferred taxes | 16 | €25k | €28k | €30k |
| Amounts payable | 17/49 | €625k | €640k | €641k |
| Amounts payable after one year | 17 | €95k | €128k | €160k |
| Amounts payable within one year | 42/48 | €529k | €510k | €480k |
| Trade debts payable within one year | 44 | €185k | €167k | €155k |
| Income statement | ||||
| Gross operating margin | 9900 | €405k | €411k | €382k |
| Operating result | 9901 | €365k | €375k | €345k |
| Financial income | 75 | €1k | €98 | €2k |
| Financial charges | 65 | €10k | €11k | €11k |
| Result before taxes | 9903 | €356k | €364k | €336k |
| Income taxes | 67/77 | €91k | €94k | €87k |
| Net result for the period | 9904 | €267k | €273k | €251k |
| Result to be appropriated | 9905 | €272k | €278k | €256k |
Former directors (1)
-
RYCKAERT-VERSCHOOTEPrivate limited companyManager· perm. rep.: Rik RYCKAERTState Gazette act 22372450 (14-11-2022)Former- → 14-11-2022
| NACE primary | Retail sale of pharmaceutical products(47730) |
| Legal form | Private limited company(610) |
| Incorporation | 28-12-1984 |
| Status | Active |
| Postal code | 9980 |
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 43014A0728/02K002 | Flanders | 512 m² | 1 · 245 m² | 11.5 m · 2 fl. |
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
14-11-2022 1 resigning, 1 reappointed
- Rik RYCKAERT, Zaakvoerder
- Rik RYCKAERT, Niet-statutair bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Rik RYCKAERT",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "de_plein_droit_dissolution",
"subkind": null,
"via_org": {
"kbo": "0426.679.937",
"name": "RYCKAERT-VERSCHOOTE",
"address": "Dorpsstraat 138, 9980 Sint-Laureins",
"country": "BE",
"legal_form": "BV"
},
"statutory": "niet_statutair",
"compensated": false,
"effective_date": null,
"evidence_quote": "De algemene vergadering besluit de huidige zaakvoerder, hierna vermeld, ontslag te geven uit zijn functie en gaat onmiddellijk over tot haar herbenoeming als niet-statutair bestuurder voor onbepaalde duur",
"decharge_status": "pending_next_agm",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_renew",
"role": "niet_statutair bestuurder",
"person": {
"rrn": null,
"name": "Rik RYCKAERT",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "renewal",
"via_org": {
"kbo": "0426.679.937",
"name": "RYCKAERT-VERSCHOOTE",
"address": "Dorpsstraat 138, 9980 Sint-Laureins",
"country": "BE",
"legal_form": "BV"
},
"statutory": "niet_statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "correction",
"role": null,
"person": null,
"reason": null,
"subkind": "rectification",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": "Philip BAUWENS",
"firm_city": null,
"firm_name": null,
"office_city": "Sint-Laureins",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2022-11-14",
"filing_date": "2022-11-09",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "buitengewone_algemene_vergadering",
"date": "2022-10-20",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0426.679.937",
"name_full": "APOTHEEK RYCKAERT-VERSCHOOTE",
"legal_form": "BV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Philip BAUWENS",
"org_rep_person_name": null,
"person_role_at_subject": "notaris"
},
"co_filed_documents": [
"Uitgifte van de akte",
"Geco\u00F6rdineerde statuten"
],
"corrected_publication_numac": null
}| Legal nameNL | APOTHEEK RYCKAERT-VERSCHOOTE |